Skip to content
Open access

Multi-dimensional attention framework for personalised Alzheimer's disease progression prediction across sporadic and genetic risk cohorts

Aug 2026 · Research Square · 0 citations · 40 references
Medicine

TL;DR

A multi-dimensional attention framework that simultaneously captures both temporal dynamics and biomarker importance to predict disease progression across three fundamentally different populations could enable precision medicine approaches for data-limited cohorts across the Alzheimer's disease spectrum.

Abstract

Alzheimer's disease progresses heterogeneously across diverse cohorts, yet current predictive models fail to capture this complexity while remaining clinically interpretable. Here we present a multi-dimensional attention framework that simultaneously captures both temporal dynamics and biomarker importance to predict disease progression across three fundamentally different populations: the general late-onset population using the Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) dataset (N=1669), cases with Down Syndrome-associated Alzheimer's disease using the Alzheimer's Biomarker Consortium - Down Syndrome (ABC-DS) dataset (N=396), and cases with autosomal dominant Alzheimer's disease using the Dominantly Inherited Alzheimer Network (DIAN) dataset (N=425). Trained on each dataset independently, our framework achieved multi-class Area Under the Receiver Operating Characteristic Curve (mAUC) values of 0.793 (TADPOLE), 0.680 (ABC-DS), and 0.902 (DIAN) when predicting individuals' future diagnostic status (cognitively normal/stable, mild cognitive impairment, or Alzheimer's disease) from their longitudinal biomarker history, outperforming conventional approaches. The model generates individual-specific attention maps revealing distinct biomarker importance over time. Transfer learning from TADPOLE—which included neuroimaging data—improved prediction performance on the imaging-free ABC-DS dataset from 0.680 to 0.771, demonstrating that disease mechanisms transcend both etiological boundaries and data modalities. Ultimately, this framework could enable precision medicine approaches for data-limited cohorts across the Alzheimer's disease spectrum.

Read PDF

Similar papers

Open access Aug 2026

Quantifying Uncertainty in Alzheimer's Disease Progression Modelling: A Variational Disease Progression Score Framework

A variational Disease Progression Score (DPS) framework is introduced that maps multimodal biomarker dynamics onto a continuous latent timeline with quantified uncertainty, offering a probabilistic foundation for patient-level prognosis and precision monitoring in Alzheimer's disease.

T. Ngamsaowaros, I. Bodala, S. Michopoulou et al. · 0 citations
Open access Oct 2026

Forecasting Alzheimer’s disease progression using non-imaging clinical features and XGBoost

Identifying progressive dementia during its prodromal stage is a challenging yet critical task for healthcare providers. Traditional clinical assessments are often not sensitive enough to detect warning signs of cognitive decline. Machine learning (ML) methods have shown promise in modeling clinical trajectories associ...

A. Gautier, L. Zheng, B. Schreurs · 0 citations
Preprint Aug 2026

Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum

Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Ba...

Ying-Ying Zhang, Kun Zhao, Guodong Liu et al. · 0 citations
Open access Aug 2026

Interpretable multimodal learning for integrating neuroimaging and genetic data in Alzheimer’s disease

R-GenIMA, an interpretable multimodal large language model that pairs a region-of-interest vision transformer with genetic prompting to jointly analyze structural MRI and single nucleotide polymorphisms, shows that interpretable multimodal AI can integrate imaging and genetics to reveal disease mechanisms.

Kun Zhao, Si-Yuan Dai, Ying-Ying Zhang et al. · 0 citations
Open access Sep 2026

Explainable Multimodal Deep Learning Framework for Longitudinal Prediction of Neurodegenerative Disease Progression with Clinical Validation

Neurodegenerative diseases, particularly Alzheimer's Disease and Parkinson's Disease, are rapidly increasing as one of the leading causes of disability, cognitive decline, and death among the elderly population worldwide. Accurately predicting long-term disease progression remains a significant research challenge due t...

Md. Ariful Islam, Moloy Biswas, Alif Laila et al. · 0 citations
Open access 2026

AN INTERPRETABLE MULTI-OMICS ELASTICNET PIPELINE FOR ALZHEIMER'S DISEASE CLASSIFICATION

Alzheimer’s disease (AD) classification from heterogeneous biomedical data remains challenging because omics feature spaces are high-dimensional, sample sizes are limited, and data integration must remain interpretable. This study developed an interpretable machine learning framwork that integrated biological interpret...

Aya Abdelaziz, Amira Gherboudj, Tunahan Çakır et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.